Compounds > 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol
Page last updated: 2024-08-26

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Carcinoma

1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banáth, JP; Durand, RE; Olive, PL1
Siemann, DW; Sutherland, RM1

Other Studies

2 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and Carcinoma

ArticleYear
The range of oxygenation in SiHa tumor xenografts.
    Radiation research, 2002, Volume: 158, Issue:2

    Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms

2002
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1992, Volume: 24, Issue:4

    Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured

1992